```

[Federal Register Volume 89, Number 243 (Wednesday, December 18, 2024)]
[Notices]
[Pages 102892-102893]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29865]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-ORD-2017-0497; FRL-12395-01-ORD]

Availability of the Draft IRIS Toxicological Review of Chloroform 
(Inhalation)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of public comment period.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is announcing a 60-
day public comment period associated with release of the draft 
Integrated Risk Information System (IRIS) Toxicological Review of 
Chloroform (Inhalation). The draft document was prepared by the Center 
for Public Health and Environmental Assessment (CPHEA) within EPA's 
Office of Research and Development (ORD).
    EPA is releasing this draft IRIS assessment for public comment in 
advance of a Science Advisory Board (SAB) managed peer review. SAB will 
convene a public meeting to discuss the draft assessment with the 
public during Step 4 of the IRIS Process. The external peer reviewers 
will consider public comments submitted to the EPA docket in response 
to this notice and any others provided during external peer review. EPA 
will consider all comments submitted to the docket when revising the 
document post-peer review. This draft assessment is not final as 
described in EPA's information quality guidelines, and it does not 
represent, and should not be construed to represent Agency policy or 
views.

DATES: The 60-day public comment period begins December 18, 2024 and 
ends February 18, 2025. Comments must be received on or before February 
18, 2025.

ADDRESSES: The IRIS Toxicological Review of Chloroform (Inhalation) 
will be available via the internet on the IRIS website at https://www.epa.gov/iris and in the public docket at http://www.regulations.gov, Docket ID No. EPA-HQ-ORD-2017-0497.

FOR FURTHER INFORMATION CONTACT: 
    For information on the public comment period, contact the ORD 
Docket at the EPA Headquarters Docket Center; telephone: 202-566-1752; 
facsimile: 202-566-9744; or email: [email protected].
    For technical information on the IRIS Toxicological Review of 
Chloroform (Inhalation) contact Mr. Dahnish Shams; email: 
[email protected]. The IRIS Program will provide updates through 
the IRIS website (https://www.epa.gov/iris) and via EPA's IRIS 
listserv. To register for the IRIS listserv, visit the IRIS website 
(https://www.epa.gov/iris) or https://www.epa.gov/iris/forms/staying-connected-integrated-risk-information-system#connect.
    For information about the peer review, please visit the EPA SAB 
website: https://sab.epa.gov/ords/sab/r/sab_apex/sab/advisoryactivitydetail?p18_id=2651&clear=18&session=309037997993.

SUPPLEMENTARY INFORMATION: 
    I. How to Submit Technical Comments to the Docket at https://www.regulations.gov. Submit your comments, identified by Docket ID No. 
EPA-HQ-ORD-2017-0497 for the Chloroform IRIS Assessment, by one of the 
following methods:
    www.regulations.gov: Follow the on-line instructions for 
submitting comments.
     Email: [email protected].
     Fax: 202-566-9744.
     Mail: U.S. Environmental Protection Agency, EPA Docket 
Center (ORD Docket), Mail Code: 28221T, 1200 Pennsylvania Avenue NW, 
Washington, DC 20460. The phone number is 202-566-1752.
    For information on visiting the EPA Docket Center Public Reading 
Room, visit https://www.epa.gov/dockets. The telephone number for the 
Public Reading Room is 202-566-1744. The public can submit comments via 
www.regulations.gov or email.
    Instructions: Direct your comments to docket number EPA-HQ-ORD-
2017-0497 for IRIS Toxicological Review of Chloroform (Inhalation). 
Please ensure that your comments are submitted within the specified 
comment period. It is EPA's policy to include all comments it receives 
in the public docket within the specified comment period without change 
and to make the comments available online www.regulations.gov, 
including any personal information provided, unless a comment includes 
information claimed to be Confidential Business Information (CBI) or 
other information for which disclosure is restricted by statute. Do not 
submit information through www.regulations.gov or email that you 
consider to be CBI or otherwise protected. The www.regulations.gov 
website is an ``anonymous access'' system, which means EPA will not 
know your identity or contact information unless you provide it in the 
body of your comment. If you send an email comment directly to EPA 
without going through www.regulations.gov,

[[Page 102893]]

your email address will be automatically captured and included as part 
of the comment that is placed in the public docket and made available 
on the internet. If you submit an electronic comment, EPA recommends 
that you include your name and other contact information in the body of 
your comment and with any disk or CD-ROM you submit. If EPA cannot read 
your comment due to technical difficulties and cannot contact you for 
clarification, EPA may not be able to consider your comment. Electronic 
files should avoid the use of special characters, any form of 
encryption, and be free of any defects or viruses. For additional 
information about EPA's public docket visit the EPA Docket Center 
homepage at www.epa.gov/epahome/dockets.htm.
    Docket: Documents in the docket are listed in the 
www.regulations.gov index. Although listed in the index, some 
information is not publicly available, e.g., CBI or other information 
whose disclosure is restricted by statute. Certain other materials, 
such as copyrighted material, are publicly available only in hard copy. 
Publicly available docket materials are available either electronically 
in www.regulations.gov or in hard copy at the ORD Docket in the EPA 
Headquarters Docket Center.

Wayne Cascio,
Director, Center for Public Health & Environmental Assessment.
[FR Doc. 2024-29865 Filed 12-17-24; 8:45 am]
BILLING CODE 6560-50-P
```